跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
AMBELVIST SOLUTION FOR INJECTION 0.1MMOL/ML
Approved
THERAPEUTIC
AMBELVIST SOLUTION FOR INJECTION 0.1MMOL/ML
Bayer AG (GERMANY)
🇸🇬 Health Sciences Authority
Approval Date
Sep 4, 2026
Approval ID
ee73f81c59dadab8
Company
Bayer AG (GERMANY)
Type
Therapeutic
Approval Details
Approval Id
ee73f81c59dadab8
Drug Name
AMBELVIST SOLUTION FOR INJECTION 0.1MMOL/ML
Product Name
AMBELVIST SOLUTION FOR INJECTION 0.1MMOL/ML
Approval Number
SIN17631P
Approval Date
2026-09-04
Registrant
BAYER (SOUTH EAST ASIA) PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, SOLUTION
Route Of Administration
INTRAVENOUS
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Sep 4, 2026
Approval ID
ee73f81c59dadab8
Type
Therapeutic
Back to HSA Approvals
AMBELVIST SOLUTION FOR INJECTION 0.1MMOL/ML - HSA Drug Approval Details
